Boehringer Ingelheim is one of the world's largest pharmaceutical companies and is exploring quantum computing for drug discovery and molecular simulation. The Ingelheim-based company is investigating quantum algorithms for protein folding, molecular dynamics, and compound screening to speed up pharmaceutical research and development.
Boehringer Ingelheim works with quantum computing providers and academic institutions to develop practical quantum chemistry applications for identifying new drug candidates and optimizing therapeutic molecules. Its quantum computing initiative focuses on computational chemistry problems where quantum algorithms could provide significant advantages over classical methods, placing the company among the early movers in quantum-enhanced drug discovery.
Quantum Specifications
Quantum Focus
software
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Frequently Asked Questions
Boehringer Ingelheim is one of the world's largest pharmaceutical companies and is exploring quantum computing for drug discovery and molecular simulation. The Ingelheim-based company is investigating quantum algorithms for protein folding, molecular dynamics, and compound screening to speed up pharmaceutical research and development.
Boehringer Ingelheim works with quantum computing providers and academic institutions to develop practical quantum chemistry applications for identifying new d...
Boehringer Ingelheim Quantum is headquartered in Ingelheim, Germany.
Boehringer Ingelheim Quantum was founded in 1885.
Boehringer Ingelheim Quantum operates in the following sectors: quantum computing, quantum chemistry, enterprise adopter, pharmaceutical.
